Ozempic
Active substance: semaglutide
INJECTION, SOLUTION · SEMAGLUTIDE 1.34 mg/mL
United StatesActive
Marketing holder: Novo Nordisk Pharmaceutical Industries, LP
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- SEMAGLUTIDE · 1.34 mg/mL
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 30 |
|
| EU 5 |
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3151-7293-9fc5-610f3a7c8f83,01a120c3-31bf-7f65-ad96-474deb517441,01a120c3-3380-727c-9b1b-d31738cab41c,01a120c3-3381-7047-b063-ace9f33496ef,01a120c3-3383-7367-9a21-a5d6d4ef2a61;count=29 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-f6d3-7bd2-8af6-abee321f9df7,01a1208d-18aa-73b1-abd9-fc177634ca24,01a1208d-1a60-773c-84b1-d104a7a9e97e,01a1208d-1a88-75bf-ae52-e015de041da2,01a1208d-1a94-7c5a-9fe7-522028ed9e94;count=26 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 0169-4130
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
- product · openFDA NDC · 0169-4130 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0169-4130 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0169-4130 · Verified 2026-10-09 · open in source